Journal article icon

Journal article

A Phase I, open-label study with escalating doses of intravenous PTK787/ZK 222584, a multi-VEGF receptor inhibitor, followed by multiple oral daily dosing to assess the absolute bioavailability of PTK787/ZK 222584 after single and multiple doses in advanced cancer patients

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, Clinical Lab Sciences, Biomedical Research Centre
Role:
Author
Expand authors...
Journal:
EJC SUPPLEMENTS
Volume:
3
Issue:
2
Pages:
427-427
Publication date:
2005-10-05
ISSN:
1359-6349
URN:
uuid:543bb4de-f2ee-41ba-9616-24f722e85081
Source identifiers:
125012
Local pid:
pubs:125012

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP